Charles River Laboratories Intl (CRL) Stock Price, Quote & News

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of serv...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 222 6000

Website: www.criver.com

Address:

251 Ballardvale Street, Wilmington, United States

OptionRunners Oct. 24 at 5:50 PM

$CRL calls are trading $22+ now. Some profit taking in them over the last couple of days though. OI down to 449.

0 · Reply

SPYmyQQQ Oct. 24 at 3:54 PM

🏛️ 🚀 $CRL up ⬆️36.50% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

ZacksResearch Oct. 24 at 2:02 PM

$CRL Q3 earnings preview — can they keep the streak alive? 📊 Charles River has beaten EPS estimates in each of the last four quarters, with an impressive average surprise of 12.84%. For Q3, the Zacks Consensus Estimate suggests a 10.4% YoY EPS decline, but a +0.61% Earnings ESP and Zacks Rank #3 hint at another possible beat. Find out if CRL can defy expectations again 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-body-17480&ADID=SYND_STOCKTWITS_TWEET_2_2776176_BODY_17480

0 · Reply

ZacksResearch Oct. 24 at 1:02 PM

$CRL — positioned for a potential earnings surprise? 👀 The preview dives into how Charles River’s setup looks heading into its Q3 report, analyzing key factors that could shape its performance and investor sentiment. Full pre-earnings breakdown here 👉 https://www.zacks.com/stock/news/2776176/heres-how-charles-river-stock-is-placed-ahead-of-q3-earnings?cid=sm-stocktwits-2-2776176-teaser-17469&ADID=SYND_STOCKTWITS_TWEET_2_2776176_TEASER_17469

0 · Reply

SPYmyQQQ Oct. 23 at 2:31 PM

🏛️ 🚀 $CRL up ⬆️33.44% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

SPYmyQQQ Oct. 20 at 10:13 PM

🏛️ 🚀 $CRL up ⬆️25.96% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

vjtweet Oct. 20 at 8:19 PM

$CRL closed half position.

0 · Reply

StockAutoPro Oct. 18 at 4:14 AM

$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.

0 · Reply

OptionRunners Oct. 17 at 7:37 PM

$CRL Buyer of the November 21st $180 calls 500 times for $11.00 ahead of earnings on 11/5

0 · Reply

MoneyGroupLLC Oct. 17 at 7:37 PM

Enter: $CRL NOV 21 2025 $175 CALLS Buy in Price: $10.40 - $11.90 Take Profit: $19.03 Stop Bleeding: $9.15 ROI Potential: 83% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 8:00 AM EDT - 3 days ago

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Oct 20, 2025, 8:00 AM EDT - 5 days ago

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

Oct 15, 2025, 8:00 AM EDT - 10 days ago

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Oct 14, 2025, 8:00 AM EDT - 11 days ago

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

Oct 8, 2025, 8:00 AM EDT - 17 days ago

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Oct 7, 2025, 7:22 AM EDT - 18 days ago

Why Charles River Stock May Struggle In Its Final Phase

Sep 16, 2025, 7:05 AM EDT - 5 weeks ago

Charles River Laboratories Announces Chief Financial Officer Transition

Sep 11, 2025, 8:00 AM EDT - 6 weeks ago

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

Sep 10, 2025, 12:40 PM EDT - 6 weeks ago

Charles River Laboratories International, Inc. (CRL) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 9, 2025, 1:09 PM EDT - 6 weeks ago

Charles River Laboratories International, Inc. (CRL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 8:00 AM EDT - 6 weeks ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Sep 3, 2025, 8:00 AM EDT - 7 weeks ago

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Aug 6, 2025, 1:30 PM EDT - 2 months ago

Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 12:50 PM EDT - 2 months ago

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing

Aug 6, 2025, 12:47 PM EDT - 2 months ago

Charles River: Margin Fears Outweigh Solid Q2

Aug 6, 2025, 7:55 AM EDT - 2 months ago

Charles River raises profit forecast on growing demand for drug development services

Aug 6, 2025, 7:00 AM EDT - 2 months ago

Charles River Laboratories Announces Second-Quarter 2025 Results

Jul 22, 2025, 8:00 AM EDT - 3 months ago

Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development

Jul 15, 2025, 8:00 AM EDT - 3 months ago

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Jun 16, 2025, 8:00 AM EDT - 4 months ago

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

Jun 2, 2025, 8:00 AM EDT - 5 months ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

May 28, 2025, 8:00 AM EDT - 5 months ago

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research

May 13, 2025, 8:00 AM EDT - 5 months ago

Charles River Laboratories to Present at Bank of America Health Care Conference

May 10, 2025, 8:49 AM EDT - 6 months ago

Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

May 7, 2025, 5:31 PM EDT - 6 months ago

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

May 7, 2025, 2:46 PM EDT - 6 months ago

Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript

May 7, 2025, 12:39 PM EDT - 6 months ago

Charles River Laboratories' Q1 Earnings Beat Consensus, Stock Trades Higher On Signs Of Demand Stabilization

May 7, 2025, 12:17 PM EDT - 6 months ago

Charles River Stock Is Having Its Best Day in 13 Years. A Board Shake-Up and Business Review Will Help.

May 7, 2025, 11:56 AM EDT - 6 months ago

Top Stock Moves Now: Charles River Labs, Disney, Supermicro, and More

DIS SMCI

May 7, 2025, 7:35 AM EDT - 6 months ago

Charles River to add new directors, review business in agreement with Elliott

May 7, 2025, 7:01 AM EDT - 6 months ago

Charles River Laboratories Announces First-Quarter 2025 Results

May 7, 2025, 7:00 AM EDT - 6 months ago

Charles River Laboratories Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value

May 7, 2025, 6:08 AM EDT - 6 months ago

Exclusive: Charles River agrees with Elliott to add new directors, review business

Apr 29, 2025, 8:00 AM EDT - 6 months ago

Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort

Apr 22, 2025, 8:00 AM EDT - 6 months ago

Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development

Apr 15, 2025, 4:30 PM EDT - 6 months ago

Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call

Apr 11, 2025, 10:44 AM EDT - 7 months ago

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

CERT SLP

Mar 25, 2025, 8:00 AM EDT - 7 months ago

Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform

Mar 11, 2025, 8:00 AM EDT - 8 months ago

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Mar 4, 2025, 4:05 AM EST - 8 months ago

FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility

Feb 25, 2025, 8:00 AM EST - 8 months ago

Charles River Announces Agreement with Singapore General Hospital

Feb 19, 2025, 4:58 PM EST - 8 months ago

Analyst Sees Charles River As Preclinical Leader But Maintains Neutral Stance

Feb 19, 2025, 3:03 PM EST - 8 months ago

Charles River Laboratories International, Inc. (CRL) Q4 2024 Earnings Call Transcript

Feb 19, 2025, 8:11 AM EST - 8 months ago

Charles River beats quarterly estimates on stable demand for drug development services

Feb 19, 2025, 7:00 AM EST - 8 months ago

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2024 Results and Provides 2025 Guidance

Feb 11, 2025, 8:00 AM EST - 9 months ago

Charles River and Deciphex Extend Global Partnership to Expand Digital Pathology Offering with Exclusive Image Management Solutions

Jan 28, 2025, 4:30 PM EST - 9 months ago

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

Jan 21, 2025, 8:00 AM EST - 9 months ago

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences

OptionRunners Oct. 24 at 5:50 PM

$CRL calls are trading $22+ now. Some profit taking in them over the last couple of days though. OI down to 449.

0 · Reply

SPYmyQQQ Oct. 24 at 3:54 PM

🏛️ 🚀 $CRL up ⬆️36.50% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

ZacksResearch Oct. 24 at 2:02 PM

0 · Reply

ZacksResearch Oct. 24 at 1:02 PM

0 · Reply

SPYmyQQQ Oct. 23 at 2:31 PM

🏛️ 🚀 $CRL up ⬆️33.44% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

SPYmyQQQ Oct. 20 at 10:13 PM

🏛️ 🚀 $CRL up ⬆️25.96% since our entry $146.26 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!

0 · Reply

vjtweet Oct. 20 at 8:19 PM

$CRL closed half position.

0 · Reply

StockAutoPro Oct. 18 at 4:14 AM

$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.

0 · Reply

OptionRunners Oct. 17 at 7:37 PM

$CRL Buyer of the November 21st $180 calls 500 times for $11.00 ahead of earnings on 11/5

0 · Reply

MoneyGroupLLC Oct. 17 at 7:37 PM

Enter: $CRL NOV 21 2025 $175 CALLS Buy in Price: $10.40 - $11.90 Take Profit: $19.03 Stop Bleeding: $9.15 ROI Potential: 83% Exit Within: 3 Weeks https://moneygroup.us/alerts

0 · Reply

JarvisFlow Oct. 17 at 1:18 PM

Mizuho updates rating for Charles River ( $CRL ) to Neutral, target set at 155 → 174.

0 · Reply

vjtweet Oct. 16 at 5:00 PM

$CRL has a position. Showing good relative strength today.

0 · Reply

SuperGreenToday Oct. 16 at 1:26 PM

$CRL Share Price: $170.72 Contract Selected: Feb 20, 2026 $170 Calls Buy Zone: $15.30 – $18.90 Target Zone: $25.65 – $31.35 Potential Upside: 58% ROI Time to Expiration: 126 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

vjtweet Oct. 13 at 7:48 PM

Not worth holding big over night positions.. don't fall for FOMO. Yet $CRL looks ok here. Small position.

0 · Reply

TalkMarkets Oct. 12 at 7:00 PM

3 #Medical Service #Industry #Stocks Poised To Counter Workforce Issues $CRL $LH $TDOC https://talkmarkets.com/content/stocks--equities/3-medical-service-industry-stocks-poised-to-counter-workforce-issues?post=527878&userid=123969

0 · Reply

RunnerSignals Oct. 7 at 10:27 PM

Wall Street turning bullish! $AMD $LRCX $CRL $HOLX $EME all caught upgrades today. LRCX seeing the biggest love with a $150 PT that's a 50% jump from $100 https://stocksrunner.com/news/2025-10-07-wall-street-analysts-signal-strong-buys

0 · Reply

StockAutoPro Oct. 6 at 4:47 PM

$CRL: Buy target $177.49 Sell target $188.46 Strong clinical trial results suggest potential growth for this animal healthcare stock.

0 · Reply

JarvisFlow Oct. 6 at 3:27 PM

William Blair has adjusted their stance on Charles River ( $CRL ), setting the rating to Outperform.

0 · Reply

Mrstock2255 Oct. 6 at 3:14 PM

$CRL how many? And your people 0!

0 · Reply

IN0V8 Oct. 3 at 4:30 PM

$CRL Barclays raises target price to $195 from $165 Barclays raises to overweight from equal-weight

0 · Reply

JarvisFlow Oct. 3 at 3:59 PM

Evercore ISI Group has updated their rating for Charles River ( $CRL ) to Outperform with a price target of 200.

0 · Reply

SweepCastApp Oct. 3 at 12:13 PM

$CRL: Unusual Options Activity Alerted PUT flow observed 100x contracts at Strike price of $150 Exp on 11/21/2025 with Premium of $40K and showing BEARISH Sentiment

0 · Reply

Market Cap	9.40B
Revenue (ttm)	4.05B
Net Income (ttm)	22.20M
EPS (ttm)	N/A
PE Ratio	17.46
Forward PE	18.38
Profit Margin	0.55%
Debt to Equity Ratio	0.69

Volume	1,741,700
Avg Vol	909,666
Day's Range	N/A - N/A
Shares Out	49.21M
Stochastic %K	92%
Beta	1.50
Analysts	Sell
Price Target	$187.15